Estimates

Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-07-29.

FY2027 EPS estimates are down 3.1% over 180 days while revenue estimates rose 2.9%

FY2028 carries the same split over 90 days — revenue +2.1%, normalized EPS -2.9%. Neither line has moved at all in the last 30 days, so this is a one-to-six-month-old revision rather than a fresh one. The feed has no 180-day mark for FY2028.

Currency: IDR · Scale: money in millions, billions, absolute · Point-in-time consensus; Δ90d is Now versus 90d.

Metric FY 180d 90d 30d Now Δ90d
EPS (normalized) FY2027 IDR 93.55 IDR 91.24 IDR 90.63 IDR 90.63 -0.7%
EPS (normalized) FY2028 IDR 107.0 IDR 103.9 IDR 103.9 -2.9%
Revenue FY2027 IDR 83,927 IDR 85,029 IDR 86,373 IDR 86,373 +1.6%
Revenue FY2028 IDR 96,490 IDR 98,540 IDR 98,540 +2.1%

Consensus has normalized EPS growing faster than revenue in each of the next three years

Currency: IDR · Scale: money in millions, billions, absolute · YoY uses the prior fiscal year from the feed; analyst count and range use the first displayed period.

Metric FY2025A FY2026E FY2027E FY2028E YoY Analysts Low / high
Revenue IDR 72,064 IDR 80,171 IDR 86,373 IDR 98,540 7 IDR 70,584 / IDR 73,163
EBITDA IDR 2,826 IDR 3,266 IDR 3,691 IDR 4,021 4 IDR 2,346 / IDR 3,221
EPS (normalized) IDR 69.56 IDR 79.58 IDR 90.63 IDR 103.9 6 IDR 62.00 / IDR 73.27
Gross margin 11.3% 11.3% 11.4% 11.5%
Dividend per share IDR 21.90 IDR 23.20 IDR 26.87 IDR 30.20

Beat / miss record

Current sequences by metric: Revenue: 1 consecutive miss.

Currency: IDR · Scale: money in millions, billions, absolute · Consensus is captured before each actual first became effective.

Quarter Metric Consensus Actual Surprise Outcome
Q1 FY2026 Revenue IDR 23,893 IDR 22,413 -6.2% Miss
Q4 FY2025 Revenue IDR 20,798 IDR 24,243 +16.6% Beat
Q3 FY2025 Revenue IDR 17,151 IDR 17,318 +1.0% Beat
Q1 FY2025 Revenue IDR 17,217 IDR 15,882 -7.8% Miss
Q4 FY2024 Revenue IDR 17,123 IDR 16,672 -2.6% Miss
Q4 FY2023 Revenue IDR 17,076 IDR 17,323 +1.4% Beat
Q4 FY2022 Revenue IDR 13,196 IDR 14,531 +10.1% Beat

Three analysts put FY2028 EBITDA anywhere from 3,306 to 5,156

The FY2027 revenue and normalized EPS ranges each carry seven estimates and are the most informative disagreement on this page. The FY2028 EBITDA range is the widest but rests on three models, which makes it thin coverage more than a settled debate.

Currency: IDR · Scale: money in millions, billions, absolute · Spread/mean is absolute high-low divided by absolute mean.

Metric Period Mean Low–high Spread/mean Analysts
Revenue FY2027E IDR 86,373 IDR 77,003–IDR 93,315 18.9% 7
EPS (normalized) FY2027E IDR 90.63 IDR 84.00–IDR 101.1 18.8% 7
EBITDA FY2027E IDR 3,691 IDR 3,045–IDR 4,352 35.4% 4
EBITDA FY2028E IDR 4,021 IDR 3,306–IDR 5,156 46.0% 3

Six buys, one outperform, one hold — and price targets from 400 to 680

The mean target of 504.3 sits above the median of 450, so the distribution is pulled by its high end rather than centred on it. Seven analysts contribute targets and no analyst carries a sell or underperform rating. This source has no market price, so none of this reads as upside.

Currency: IDR · Scale: money in millions, billions, absolute · Analyst counts shown explicitly.

Street view Reading Analysts
Recommendation mix Buy 6, Outperform 1, Hold 1, Underperform 0, Sell 0 8
Consensus score 1.38 8
Target price mean IDR 504.3; median IDR 450.0; high IDR 680.0; low IDR 400.0 7

Coverage caution: FY2028 rests on three analysts, and several lines carry no count at all

FY2028 revenue, GAAP net income and EBITDA each rest on three estimates and normalized EPS on four, against six or seven on the FY2026 and FY2027 revenue and EPS lines. Free cash flow, capex, cash from operations, net debt and ROE are supplied as a mean only, with no analyst count and no range, so their moves cannot be sized for breadth or dispersion.